BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28742270)

  • 1. Malignancy screening in autoimmune myositis among Australian rheumatologists.
    Dutton K; Soden M
    Intern Med J; 2017 Dec; 47(12):1367-1375. PubMed ID: 28742270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing standardised treatment for adults with myositis and different phenotypes: an international survey of current prescribing preferences.
    Tansley S; Shaddick G; Christopher-Stine L; Sharp C; Dourmishev L; Maurer B; Chinoy H; McHugh N
    Clin Exp Rheumatol; 2016; 34(5):880-884. PubMed ID: 27243269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.
    Tiller G; Renton WD; Tan J; Whittle S; Avery J; Munro J; Buchbinder R
    Pediatr Rheumatol Online J; 2022 Jul; 20(1):52. PubMed ID: 35870945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
    Allenbach Y; Keraen J; Bouvier AM; Jooste V; Champtiaux N; Hervier B; Schoindre Y; Rigolet A; Gilardin L; Musset L; Charuel JL; Boyer O; Jouen F; Drouot L; Martinet J; Stojkovic T; Eymard B; Laforêt P; Behin A; Salort-Campana E; Fain O; Meyer A; Schleinitz N; Mariampillai K; Grados A; Benveniste O
    Brain; 2016 Aug; 139(Pt 8):2131-5. PubMed ID: 27086869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population.
    McCarthy EM; Azeez MA; Fitzpatrick FM; Donnelly S
    J Clin Rheumatol; 2012 Aug; 18(5):237-41. PubMed ID: 22832287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some aspects of idiopathic myopathies of childhood].
    Zuber Z; Rutkowska-Sak L
    Ann Acad Med Stetin; 2012; 58(1):11-7. PubMed ID: 23547388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    J Dermatol; 2019 Jan; 46(1):e1-e18. PubMed ID: 30562845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of dermatomyositis and polymyositis to internal malignancy.
    Callen JP; Hyla JF; Bole GG; Kay DR
    Arch Dermatol; 1980 Mar; 116(3):295-8. PubMed ID: 7369745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice.
    Hočevar A; Rotar Z; Krosel M; Čučnik S; Tomšič M
    Ann Rheum Dis; 2018 Dec; 77(12):e90. PubMed ID: 29237619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Idiopathic inflammatory myopathies from the viewpoint of a neurologist].
    Shimizu J
    Brain Nerve; 2013 Nov; 65(11):1269-74. PubMed ID: 24200604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Myopathies.
    Mammen AL
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1852-1870. PubMed ID: 27922497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists.
    Kohsaka H; Mimori T; Kanda T; Shimizu J; Sunada Y; Fujimoto M; Kawaguchi Y; Jinnin M; Muro Y; Ishihara S; Tomimitsu H; Ohta A; Sumida T
    Mod Rheumatol; 2019 Jan; 29(1):1-19. PubMed ID: 30565491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic work-up of cancer-associated myositis.
    Selva-O'Callaghan A; Martinez-Gómez X; Trallero-Araguás E; Pinal-Fernández I
    Curr Opin Rheumatol; 2018 Nov; 30(6):630-636. PubMed ID: 29965856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of idiopathic inflammatory myopathy in Hungary].
    Nagy-Vincze M; Bodoki L; Griger Z; Dankó K
    Orv Hetil; 2014 Oct; 155(41):1643-6. PubMed ID: 25282109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis and polymyositis) in Japan].
    Hatano H
    Hautarzt; 1982 Jul; 33(7):355-8. PubMed ID: 7107279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world implications of IMACS malignancy screening guidelines for idiopathic inflammatory myopathies: An evaluation of compliance and economic impact at a tertiary referral center.
    Teh I; Huang V; Oon S; Day J
    Int J Rheum Dis; 2024 May; 27(5):e15198. PubMed ID: 38769913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritis.
    Hopkins AM; Wiese MD; O'Doherty CE; Proudman SM
    Clin Rheumatol; 2017 Apr; 36(4):791-798. PubMed ID: 27888342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EVOLVE: The Australian Rheumatology Association's 'top five' list of investigations and interventions doctors and patients should question.
    Morrisroe K; Nakayama A; Soon J; Arnold M; Barnsley L; Barrett C; Brooks PM; Hall S; Hanrahan P; Hissaria P; Jones G; Katikireddi VS; Keen H; Laurent R; Nikpour M; Poulsen K; Robinson P; Soden M; Wood N; Cook N; Hill C; Buchbinder R
    Intern Med J; 2018 Feb; 48(2):135-143. PubMed ID: 29080286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.